A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Clinical trial NCT02419612 · COMPLETED
Trial details
- NCT number
- NCT02419612
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-14
- Primary completion
- 2017-08-29
- Enrollment
- 444
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.